
Barclays analyst Glen Santangelo raised the firm’s price target on Cencora (COR) to $415 from $350 and keeps an Overweight rating on the shares. The firm views the company’s initial
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| COR | Cencora | 348.31 | -8.20 | -2.30% |
| Name | Price | % Change | |
|---|---|---|---|
| $348.31 | -2.30% |

Barclays analyst Glen Santangelo raised the firm’s price target on Cencora (COR) to $415 from $350 and keeps an Overweight rating on the shares. The firm views the company’s initial

Wells Fargo raised the firm’s price target on Cencora (COR) to $400 from $395 and keeps an Overweight rating on the shares. The firm says momentum in Q4 2026 remained

The Federal Trade Commission sued to block Covetrus and its owners, Clayton, Dubilier & Rice and TPG Inc., from acquiring its closest competitor, MWI Veterinary Supply Inc., for $3.5B from

JPMorgan analyst Lisa Gill raised the firm’s price target on Cencora (COR) to $413 from $390 and keeps an Overweight rating on the shares. Published first on TheFly – the

BofA raised the firm’s price target on Cencora (COR) to $360 from $345 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate source for

Evercore ISI raised the firm’s price target on Cencora (COR) to $380 from $350 and keeps an Outperform rating on the shares. Published first on TheFly – the ultimate source

Baird analyst Eric Coldwell raised the firm’s price target on Cencora (COR) to $405 from $375 and keeps an Outperform rating on the shares. The firm updated its model following

Cencora, Inc. (($COR)) has held its Q4 earnings call. Read on for the main highlights of the call. Cencora’s earnings call carried a broadly positive tone, led by record fiscal

Cencora ( ($COR) ) has issued an update. Cencora recently completed a restructuring of its operating model to strengthen execution and improve visibility, reorganizing business components into Pharmaceutical Distribution and

Cencora (COR) announced that it is realigning its corporate and reporting structure to strengthen execution and visibility. To better support its specialty provider and manufacturer partners and capitalize on the
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Assigned | Nov 17, 2026 | ||||
| buy | Assigned | Nov 17, 2026 | ||||
| hold | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| hold | Reiterated | Nov 5, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| buy | Assigned | Oct 30, 2026 | ||||
| buy | Reiterated | Oct 20, 2026 | ||||
| buy | Reiterated | Oct 16, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 3, 2027TBA | $66.90B | $4.58 | $90.44B | 0.13 | 19.54 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.